Who owns NUVECTIS PHARMA INC?
- Ticker: NVCT
- CUSIP Number: 67080t108
Tip: Access positions for across all investors
Analyze quarterly positions in Nuvectis Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nuvectis Pharma stock
Who bought or sold NUVECTIS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 846k | $6.4M | 21% | Dec 2025 |
|
| BlackRock | 764k | $5.9M | -2% | Mar 2026 |
|
| Vanguard Capital Management | 660k | $5.1M | 100% | Mar 2026 |
|
| Iridian Asset Management | 652k | $5.0M | 11% | Mar 2026 |
|
| Occam Crest Management | 407k | $3.1M | 100% | Mar 2026 |
|
| Geode Capital Management | 384k | $3.0M | 6% | Mar 2026 |
|
| Baldwin Brothers | 379k | $2.9M | -3% | Mar 2026 |
|
| Susquehanna International | 195k | $1.5M | 92% | Dec 2025 |
|
| State Street Corporation | 155k | $1.2M | 13% | Dec 2025 |
|
| Northern Trust | 116k | $879k | 9% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 115k | $888k | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 92k | $712k | 100% | Mar 2026 |
|
| Citadel Advisors | 78k | $606k | -14% | Mar 2026 |
|
| Oppenheimer & Co | 74k | $569k | 0% | Mar 2026 |
|
| Paul Kendrigan | 59k | $456k | 0% | Mar 2026 |
|
| Charles Schwab Investment Management | 44k | $332k | 16% | Dec 2025 |
|
| Goldman Sachs Group | 41k | $318k | 55% | Mar 2026 |
|
| UBS Group | 39k | $298k | 360% | Mar 2026 |
|
| Bank of New York Mellon | 30k | $234k | -4% | Mar 2026 |
|
| CIBC Bancorp USA | 26k | $198k | 100% | Mar 2026 |
|
| Barclays | 24k | $183k | 31% | Dec 2025 |
|
| Morgan Stanley | 23k | $175k | -19% | Mar 2026 |
|
| Austin Wealth Management | 20k | $154k | 0% | Mar 2026 |
|
| Jane Street | 18k | $142k | 3% | Mar 2026 |
|
| Martingale Asset Management | 18k | $139k | 100% | Mar 2026 |
|
| Nuveen | 17k | $130k | 0% | Mar 2026 |
|
| Edmond De Rothschild Holding | 15k | $117k | 0% | Mar 2026 |
|
| Bank of America Corporation | 15k | $115k | 100% | Mar 2026 |
|
| Atlantic Trust | 15k | $110k | 100% | Dec 2025 |
|
| Avalon Trust | 14k | $108k | 0% | Mar 2026 |
|
| Nations Financial Group | 13k | $101k | 0% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $98k | 0% | Mar 2026 |
|
| Rhumbline Advisers | 8.7k | $67k | 3% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 7.4k | $57k | 2% | Mar 2026 |
|
| FMR | 7.2k | $54k | 10661% | Dec 2025 |
|
| Vanguard Global Advisers | 5.8k | $45k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 5.6k | $43k | -67% | Mar 2026 |
|
| New York State Common Retirement Fund | 5.0k | $39k | 0% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 3.8k | $29k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.5k | $27k | 0% | Mar 2026 |
|
| Nbc Securities | 3.0k | $23k | 0% | Mar 2026 |
|
| Tower Research Capital | 1.4k | $11k | -63% | Dec 2025 |
|
| Summit Investment Advisors | 1.3k | $10k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 1.3k | $10k | -96% | Mar 2026 |
|
| Legal & General Group | 1.2k | $9.1k | -18% | Mar 2026 |
|
| Russell Investments | 1.1k | $8.2k | 0% | Mar 2026 |
|
| California State Teachers Retirement System | 837.00 | $6.5k | -12% | Mar 2026 |
|
| Citigroup | 824.00 | $6.4k | 100% | Mar 2026 |
|
| GAMMA Investing | 645.00 | $5.0k | 277% | Mar 2026 |
|
| Spire Wealth Management | 300.00 | $2.3k | 0% | Mar 2026 |
|
| Sterling Capital Management | 100.00 | $773.000000 | 19% | Mar 2026 |
|
| Steward Partners Investment Advisory | 100.00 | $773.000000 | 0% | Mar 2026 |
|
| CWM | 33.00 | $0 | -6% | Dec 2025 |
|
| Pnc Financial Services | 23.00 | $177.999300 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 9.00 | $70.000200 | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 2.00 | $16.000000 | 100% | Mar 2026 |
|
| Essential Partners | 2.00 | $15.000000 | 100% | Mar 2026 |
|
| Rothschild Investment | 1.00 | $8.000000 | 100% | Mar 2026 |
|
| Sunbelt Securities | 1.00 | $8.000000 | 100% | Mar 2026 |
|
Who sold out of Nuvectis Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 43k | $258k |
| XTX Topco | Sep 2025 | 15k | $90k |
| Marshall Wace | Sep 2025 | 11k | $64k |
| Jpmorgan Chase & Co | Sep 2025 | 5.3k | $32k |
| Amalgamated Bank | Dec 2025 | 486.00 | $4.0k |